| Report description | | | | follows: |
| Technological innovations in the medical device | | | | • Diagnostic imaging (nuclear imaging, interventional |
| industry have led to a radical transformation in patient | | | | radiology, capsule endoscopy and others) |
| care. This report identifies the sectors with the | | | | • Drug delivery (needle free injections, transdermal |
| industry's most important developments related to | | | | systems, inhalation system, infusion system) |
| patient care, clinical outcomes, and new product | | | | • Molecular diagnostics (biosensors, proteomics, |
| development. While the scope of the report is limited | | | | nanotechnology, and others) |
| to the top ten technologies only, it covers almost the | | | | • Mobility aid technologies |
| entire medical device market. | | | | • Minimal/non-invasive surgery (stents, bariatric |
| Scientific and medical technology breakthroughs – | | | | surgery, medical robotics and others) |
| such as minimally invasive surgery (MIS) – have | | | | • Micro-fluids and MEMS (Miniature medical |
| accelerated the accuracy of clinical outcomes and | | | | pressure sensors, bio chips, protein chips) |
| have also reduced recovery times and the medical | | | | • Non-invasive monitoring (continuous blood |
| costs borne by patients. This has led to radical | | | | glucose monitoring) |
| transformation in patient care. | | | | • Biomaterials (bionic limbs, joint replacement, |
| IT integration in medical imaging and medical devices | | | | antimicrobial wound dressing and others) |
| has given a significant boost to the healthcare | | | | • Bio-implants (neurostimulation and others) |
| industry, a trend that is apparent in the market | | | | • Tele-medicines |
| growth of drug eluting stents and telemedicine | | | | Each section will provide market data, market drivers, |
| technologies. The markets covered in the report | | | | trends and opportunities, top-selling products, key |
| have a current potential of $454.3 billion and are | | | | players, and competitive outlook. This report will also |
| expected to grow at a CAGR of 9.8% between | | | | provide more than 100 market tables for various |
| 2009 and 2014. | | | | geographic regions covering the sub-segments and |
| Market estimates and forecast | | | | micro-markets. In addition, the report also provides |
| The report provides in-depth market estimates and | | | | 50 company profiles for each of its sub-segments. |
| forecast for top ten medical device technologies as | | | | |